What is the recommended duration of cefixime treatment for enteric fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duration of Cefixime in Enteric Fever

For enteric fever (typhoid), cefixime should be administered for 7-10 days at a dose of 15 mg/kg twice daily (maximum 400 mg/day), though current evidence suggests cefixime is NOT a preferred first-line agent due to inferior efficacy compared to alternatives.

Critical Context: Cefixime's Declining Role

The evidence reveals a significant problem with cefixime for enteric fever treatment. A high-quality randomized trial demonstrated that cefixime had a 37.6% treatment failure rate compared to only 3.5% with gatifloxacin 1. This dramatic difference led to early trial termination by the safety monitoring board. The median fever clearance time was 138 hours with cefixime versus 92 hours with gatifloxacin 1.

Recommended Treatment Duration When Cefixime Must Be Used

Standard Dosing Protocol

  • Duration: 7-10 days minimum 2
  • Adult dose: 400 mg once daily 3
  • Pediatric dose: 20 mg/kg/day in two divided doses (maximum 400 mg/day) 2
  • Alternative pediatric regimen: 16 mg/kg/day for 14 days showed clinical cure rates of 71% 4

When to Extend Beyond 7 Days

The WHO guideline recommends cefixime as a second-line option for multidrug-resistant strains 5, but clinical data suggests:

  • Minimum 12 days may be needed for adequate response 6
  • One study using 14-day courses showed better outcomes 4
  • Treatment should continue until clinical resolution is achieved

Preferred Alternatives (Better Efficacy)

Current evidence strongly favors these options over cefixime:

First-Line Choices

  1. Azithromycin: 20 mg/kg/day for 5-7 days 2, 5

    • 85% clinical cure rate vs 71% with cefixime 4
    • Faster fever clearance (5.8 days vs 7.1 days) 4
  2. Ceftriaxone (IV): 80 mg/kg/day for 5-7 days 2, 5

    • Superior to cefixime in head-to-head trials 1
    • Preferred for severe cases
  3. Ciprofloxacin: 15 mg/kg twice daily for 7-10 days 2, 5

    • Only in areas without quinolone resistance

Critical Clinical Pitfalls

Why Cefixime Often Fails

  • Inadequate bactericidal levels: Oral cefixime achieves lower and less sustained blood levels than parenteral ceftriaxone 7
  • High treatment failure rates: 27% acute clinical failure in controlled trials 1
  • Slower clinical response: Significantly longer fever clearance times 4, 1

Resistance Considerations

  • Cefixime is recommended only for multidrug-resistant strains (resistant to chloramphenicol, ampicillin, trimethoprim-sulfamethoxazole) 5
  • In regions with extensively drug-resistant (XDR) typhoid, cefixime may be completely ineffective
  • 88.7% of isolates in one study were MDR, and 93.5% were nalidixic acid-resistant 4

Practical Treatment Algorithm

Step 1: Assess local resistance patterns

  • If quinolone-sensitive → Use ciprofloxacin or gatifloxacin
  • If quinolone-resistant but cephalosporin-sensitive → Consider azithromycin first

Step 2: If cefixime must be used (limited alternatives):

  • Start 400 mg daily (adults) or 20 mg/kg/day divided (children)
  • Plan for minimum 7-10 days
  • Monitor fever clearance closely

Step 3: Assess response at 72-96 hours

  • If fever persists beyond 5 days → Switch to azithromycin or ceftriaxone
  • If clinical deterioration → Switch immediately to IV ceftriaxone

Step 4: Complete full course

  • Minimum 7 days if excellent response
  • Extend to 10-14 days if slow response
  • Follow-up at 8 weeks to detect relapse (2-4% risk) 6

Combination Therapy (Emerging Strategy)

Azithromycin + cefixime combination is under investigation 8 based on the rationale that:

  • Azithromycin targets intracellular bacteria
  • Cefixime targets extracellular bacteria
  • Combination may prevent resistance emergence

However, this remains experimental and is not yet standard practice.

Key Monitoring Parameters

  • Fever clearance time: Should occur within 5-7 days
  • Clinical improvement: Appetite return, reduced abdominal pain
  • Warning signs of failure: Persistent fever >7 days, worsening symptoms, complications (perforation, bleeding)
  • Relapse surveillance: Follow-up at 4-8 weeks post-treatment

2, 5, 4, 1, 6

Related Questions

What is the recommended cefixime dose for uncomplicated typhoid fever in adults and children, and how should it be adjusted for renal impairment or resistant infections?
In a 3‑year‑8‑month‑old Indian boy weighing 12.4 kg who presents with a 9‑day fever unresponsive to oral cefixime, abdominal pain, loose stools, mild cough, anemia (hemoglobin 8.9 g/dL, microcytic), leukopenia, thrombocytopenia, elevated C‑reactive protein, mild hepatosplenomegaly, and a household contact with pulmonary tuberculosis on treatment, and who has incomplete immunizations, what are the most important next diagnostic steps in order of priority, the recommended antibiotic change for suspected enteric fever considering local resistance patterns and his prior amoxicillin rash, the evaluation and preventive therapy for tuberculosis exposure, the investigation and treatment of his anemia and growth faltering, which investigations are essential today versus can be delayed given limited resources, and the appropriate catch‑up immunization schedule according to Indian guidelines (IAP, UIP, NTEP, ICMR)?
What is the appropriate cefixime dosage for treating typhoid fever in adults and children, and how should it be adjusted in patients with renal impairment?
What is the recommended cefixime dosage for a child with typhoid fever?
What is the recommended dose of cefixime (Cefixime) for the treatment of typhoid fever?
What is the optimal management of mild metabolic acidosis in a male patient residing in a skilled nursing facility?
When should oral sodium bicarbonate be started in a patient with low serum bicarbonate, what initial dose is recommended, and how should the therapy be monitored?
What are the latest guideline updates for the management of neutropenia in systemic lupus erythematosus (SLE)?
What is the recommended approach to assess a critically ill patient?
Is fried chicken permissible on a low‑residue diet?
How should a patient with a blood pressure of 170/40 mm Hg be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.